SCHEDULE 13G/A: Sabby Entities Disclose 4.9% Passive Stake in Revelation Biosciences

Sabby Management, LLC, Sabby Volatility Warrant Master Fund Ltd, and Hal Mintz have reported a passive beneficial ownership of 4.9% in Revelation Biosciences, Inc. common stock.

Summary

• Sabby Management, LLC, Sabby Volatility Warrant Master Fund Ltd, and Hal Mintz have filed an Amendment No. 1 to Schedule 13G, disclosing their beneficial ownership in Revelation Biosciences, Inc.
• Each reporting person, including Sabby Management, LLC, Sabby Volatility Warrant Master Fund Ltd, and Hal Mintz, beneficially owns 416,989 shares of Revelation Biosciences, Inc. Common Stock.
• This aggregate amount represents 4.9% of the class of Revelation Biosciences, Inc. Common Stock.
• The reporting persons hold shared voting power and shared dispositive power over all 416,989 shares, with no sole voting or dispositive power.
• The filing indicates that the securities were acquired and are held for passive investment purposes, not for changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: This is a standard beneficial ownership disclosure (Schedule 13G) indicating a passive stake, which is generally neutral in sentiment as it does not convey operational performance or strategic changes.

Industry Context

This filing is a standard disclosure of beneficial ownership by an institutional investor group, indicating a passive stake in a publicly traded company. It does not provide information on broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: Disclosure of a significant passive investor holding 4.9% of common stock, providing transparency on major ownership stakes.

Key Dates

Keywords

Revelation Biosciences, Sabby Management, Sabby Volatility Warrant Master Fund, Hal Mintz, Schedule 13G, beneficial ownership, passive investment, common stock, SEC filing